Related Experiment Video

Updated: Mar 8, 2026

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
13:20

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro

Published on: July 17, 2018

10.9K

MLF1 is a proapoptotic antagonist of HOP complex-mediated survival

Yi Sun1, Jyh-Rong Chao2, Wu Xu3

  • 1Department of Oncology, ShiJiaZhuangShi First Hospital, 36 FanXiLu, ShiJiaZhuangShi, Hebei 050011, PR China; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105-3678, USA.

Biochimica Et Biophysica Acta. Molecular Cell Research
|February 1, 2017
PubMed

Insights

Myeloid leukemia factor 1 (MLF1) negatively regulates the HAX1/HtrA2-OMI/PARL (HOP) complex, promoting apoptosis. Deleting MLF1 in Hax1-deficient mice reverses lymphopenia and neurodegeneration, extending lifespan.

Area of Science:

  • Mitochondrial biology
  • Cell death pathways
  • Protein complex regulation

Background:

  • The HAX1/HtrA2-OMI/PARL (HOP) complex generates anti-apoptotic signals via HtrA2/OMI activation.
  • This activation is mediated by PARL recruitment to HAX1 on the inner mitochondrial membrane.

Purpose of the Study:

  • To investigate the role of myeloid leukemia factor 1 (MLF1) in regulating the HOP mitochondrial complex.
  • To elucidate the mechanism by which MLF1 influences cell survival and apoptosis.

Main Methods:

  • Co-immunoprecipitation and Western blotting to assess protein interactions.
  • Cell viability assays to evaluate apoptosis.
  • In vivo studies using Hax1 knockout mouse models.

Main Results:

  • MLF1 physically and functionally associates with HAX1 and HtrA2.
  • MLF1 binding displaces HtrA2 from the HOP complex, inhibiting its activation and inducing apoptosis.
  • Overexpression of HAX1 counteracts MLF1's pro-apoptotic effects.
  • Mlf1 deletion in Hax1-/- mice ameliorates lymphopenia and neurodegeneration, significantly increasing lifespan.

Conclusions:

  • MLF1 acts as a pro-apoptotic antagonist by disrupting the HOP mitochondrial complex.
  • Targeting MLF1 interactions with the HOP complex offers a potential therapeutic strategy for diseases involving HAX1 deficiency.
Keywords:
ApoptosisHS1-associated protein X-1Myeloid leukemia factor 1Neurodegeneration

More Related Videos

Identifying Protein-protein Interaction Sites Using Peptide Arrays07:44

Identifying Protein-protein Interaction Sites Using Peptide Arrays

Published on: November 18, 2014

18.7K
Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

11.4K

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.1K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.8K